Immunotherapy With APC8015 (Sipuleucel-T, Provenge) for Asymptomatic, Metastatic, Hormone-Refractory Prostate Cancer

Clinical trial NCT01133704 · COMPLETED

Trial details

NCT number: NCT01133704
Sponsor: Dendreon
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hormone-Refractory Prostate Cancer

Start date: 2000-05-01
Primary completion: 2003-03-01
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.